Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Su TH"" wg kryterium: Autor


Tytuł :
Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan.
Autorzy :
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2020 Dec; Vol. 119 (12), pp. 1871-1875. Date of Electronic Publication: 2020 Jun 14.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis C, Chronic*/drug therapy
Antiviral Agents/*therapeutic use
Aminoisobutyric Acids ; Carbamates ; Cyclopropanes ; Drug Combinations ; Genotype ; Heterocyclic Compounds, 4 or More Rings ; Humans ; Lactams, Macrocyclic ; Leucine/analogs & derivatives ; Proline/analogs & derivatives ; Quinoxalines ; Ribavirin/therapeutic use ; Sofosbuvir/therapeutic use ; Sulfonamides ; Sustained Virologic Response ; Taiwan
Czasopismo naukowe
Tytuł :
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy.
Autorzy :
Chang WY; Department of Internal Medicine, National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan.
Chiu YC; Department of Gastroenterology and Hepatology, National Cheng Kung University Hospital, Tainan, Taiwan.
Chiu FW; Division of Gastroenterology & Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Hsu YC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, E-Da Hospital/I-Shou University, Kaohsiung, Taiwan.
Tseng TC; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Cheng PN; Department of Gastroenterology and Hepatology, National Cheng Kung University Hospital, Tainan, Taiwan.
Yang SS; Division of Gastroenterology & Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan.; PhD Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.
Liu CJ; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Su TH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine Taipei, Taiwan.
Liu CH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taiwan.
Kao JH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2020 Sep 14; Vol. 222 (8), pp. 1345-1352.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Withholding Treatment*
Antineoplastic Agents, Immunological/*therapeutic use
Antiviral Agents/*therapeutic use
Hepatitis B, Chronic/*prevention & control
Rituximab/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; DNA, Viral/blood ; Female ; Guanine/analogs & derivatives ; Guanine/therapeutic use ; Hematologic Neoplasms/drug therapy ; Hepatitis B Surface Antigens/blood ; Hepatitis B virus/drug effects ; Hepatitis B, Chronic/drug therapy ; Hepatitis B, Chronic/virology ; Humans ; Liver Failure/virology ; Male ; Middle Aged ; Recurrence ; Retrospective Studies ; Risk Factors ; Tenofovir/therapeutic use ; Viral Load ; Virus Activation/drug effects ; Young Adult
Czasopismo naukowe
Tytuł :
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data.
Autorzy :
Hong CM; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Liu CH; Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen YW; Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.
Kao JH; Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: .
Liu CJ; Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi [J Microbiol Immunol Infect] 2020 Aug; Vol. 53 (4), pp. 569-577. Date of Electronic Publication: 2018 Sep 26.
Typ publikacji :
Journal Article
MeSH Terms :
Antiviral Agents/*therapeutic use
Hepacivirus/*drug effects
Hepatitis C, Chronic/*drug therapy
RNA, Viral/*blood
Aged ; Aged, 80 and over ; Antiviral Agents/classification ; Drug Therapy, Combination ; Female ; Genotype ; Hepacivirus/classification ; Hepacivirus/genetics ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Taiwan
Czasopismo naukowe
Tytuł :
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chou SW; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Chen DS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Aug 01; Vol. 147 (3), pp. 901-908. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*therapeutic use
Hepatitis C, Chronic/*drug therapy
Interferons/*therapeutic use
Mouth Neoplasms/*epidemiology
Ribavirin/*therapeutic use
Adult ; Aged ; Case-Control Studies ; Confounding Factors, Epidemiologic ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł :
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis.
Autorzy :
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Peng CY; School of Medicine, China Medical University, Taichung, Taiwan.; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Fang YJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Kao WY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Yang SS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taipei, Taiwan.; Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Lin CK; Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Lai HC; School of Medicine, China Medical University, Taichung, Taiwan.; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Su WP; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Fang SU; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Chang CC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. .; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan. .; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Jun 08; Vol. 10 (1), pp. 9180. Date of Electronic Publication: 2020 Jun 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amides/*therapeutic use
Antiviral Agents/*therapeutic use
Benzofurans/*therapeutic use
Carbamates/*therapeutic use
Cyclopropanes/*therapeutic use
Hepacivirus/*drug effects
Hepatitis C, Chronic/*drug therapy
Imidazoles/*therapeutic use
Quinoxalines/*therapeutic use
Sulfonamides/*therapeutic use
Asian Continental Ancestry Group ; Drug Resistance, Viral/drug effects ; Drug Therapy, Combination/methods ; Female ; Genotype ; Humans ; Male ; Middle Aged ; Renal Dialysis/adverse effects ; Sustained Virologic Response
Czasopismo naukowe
Tytuł :
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Yang SS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taipei, Taiwan.; Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Peng CY; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.; School of Medicine, China Medical University, Taichung, Taiwan.
Lin WT; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Journal of viral hepatitis [J Viral Hepat] 2020 Jun; Vol. 27 (6), pp. 568-575. Date of Electronic Publication: 2020 Feb 06.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis C, Chronic*/drug therapy
Aminoisobutyric Acids/*therapeutic use
Antiviral Agents/*therapeutic use
Benzimidazoles/*therapeutic use
Cyclopropanes/*therapeutic use
Lactams, Macrocyclic/*therapeutic use
Leucine/*analogs & derivatives
Proline/*analogs & derivatives
Pyrrolidines/*therapeutic use
Quinoxalines/*therapeutic use
Renal Insufficiency, Chronic/*complications
Sulfonamides/*therapeutic use
Genotype ; Hepacivirus ; Humans ; Leucine/therapeutic use ; Proline/therapeutic use ; Retrospective Studies ; Sustained Virologic Response ; Taiwan
Czasopismo naukowe
Tytuł :
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.
Autorzy :
Yang HI; Genomics Research Center, Academia Sinica, Taipei, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Yeh ML; Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Wong GL; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.
Peng CY; Department of Gastroenterology, China Medical University Hospital, Taichung, Taiwan.
Chen CH; Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Trinh HN; San Jose Gastroenterology, San Jose, California, USA.
Cheung KS; Department of Medicine, The University of Hong Kong, Hong Kong.
Xie Q; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Peopole's Republic of China.
Su TH; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Kozuka R; Department of Hepatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Lee DH; Department of Gastroenterology, Good Gang-An Hospital, Busan, South Korea.
Ogawa E; Department of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan.
Zhao C; Department of Cirrhosis, Institute of Liver Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, Peopole's Republic of China.
Ning HB; Department of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou, Peopole's Republic of China.
Huang R; Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, Peopole's Republic of China.
Li J; Palo Alto Medical Foundation, Mountain View Division, Mountain View, California, USA.
Zhang JQ; Chinese Hospital, San Francisco, California, USA.
Ide T; Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan.
Xing H; Beijing Ditan Hospital, Capital Medical University, Beijing, Peopole's Republic of China.
Iwane S; Department of Internal Medicine, Saga University Hospital, Saga, Japan.
Takahashi H; Department of Internal Medicine, Saga University Hospital, Saga, Japan.
Wong C; Wong Clinics, San Francisco, California, USA.
Wong C; Wong Clinics, San Francisco, California, USA.
Lin CH; Department of Gastroenterology, China Medical University Hospital, Taichung, Taiwan.
Hoang J; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA.
Le A; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA.
Henry L; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA.
Toyoda H; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
Ueno Y; Department of Gastroenterology, Yamagata University, Yamagata, Japan.
Gane EJ; Liver Transplant Unit, University of Auckland, Auckland, New Zealand.
Eguchi Y; Department of Internal Medicine, Saga University Hospital, Saga, Japan.
Kurosaki M; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
Wu C; Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, Peopole's Republic of China.
Liu C; Department of Cirrhosis, Institute of Liver Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, Peopole's Republic of China.
Shang J; Department of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou, Peopole's Republic of China.
Furusyo N; Department of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan.
Enomoto M; Department of Hepatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Kao JH; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yuen MF; Department of Medicine, The University of Hong Kong, Hong Kong.
Yu ML; Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Nguyen MH; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2020 Jan 14; Vol. 221 (3), pp. 389-399.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Research Design*
Antiviral Agents/*adverse effects
Antiviral Agents/*therapeutic use
Carcinoma, Hepatocellular/*etiology
Hepatitis B virus/*genetics
Hepatitis B, Chronic/*drug therapy
Liver Neoplasms/*etiology
Administration, Oral ; Adult ; Antiviral Agents/administration & dosage ; Asia/ethnology ; Asian Continental Ancestry Group ; Cohort Studies ; DNA, Viral/genetics ; Data Accuracy ; Female ; Hepatitis B, Chronic/ethnology ; Hepatitis B, Chronic/virology ; Humans ; Male ; Middle Aged ; Proportional Hazards Models ; ROC Curve ; Random Allocation ; Risk Assessment
Czasopismo naukowe
Tytuł :
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chou SW; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Lin CH; Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2019 Dec; Vol. 34 (12), pp. 1882-1890. Date of Electronic Publication: 2019 Sep 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*therapeutic use
Hepatitis C, Chronic/*drug therapy
Parkinsonian Disorders/*epidemiology
Adult ; Aged ; Cohort Studies ; Female ; Follow-Up Studies ; Hepatitis C, Chronic/complications ; Humans ; Interferon-alpha/therapeutic use ; Male ; Middle Aged ; Parkinsonian Disorders/complications ; Polyethylene Glycols/therapeutic use ; Recombinant Proteins/therapeutic use ; Risk ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Shih YL; Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Yang SS; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Taichung Veterans General Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.
Lin CL; Department of Gastroenterology, Taipei City Hospital, Renai Branch, Taipei, Taiwan.
Fang YJ; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Cheng PN; Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
Chen CY; Department of Internal Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan.
Peng CY; Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Hsieh TY; Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Chiu YC; Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2019 Nov; Vol. 34 (11), pp. 1977-1983. Date of Electronic Publication: 2019 May 27.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Genotype*
Renal Dialysis*
Anilides/*administration & dosage
Antiviral Agents/*administration & dosage
Carbamates/*administration & dosage
Hepacivirus/*genetics
Hepatitis C/*drug therapy
Hepatitis C/*virology
Macrocyclic Compounds/*administration & dosage
Ritonavir/*administration & dosage
Adult ; Aged ; Humans ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Hong CM; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Tseng TC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2019 Sep; Vol. 34 (9), pp. 1620-1625. Date of Electronic Publication: 2019 Feb 17.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Antiviral Agents/*therapeutic use
Hepacivirus/*drug effects
Hepatitis C, Chronic/*drug therapy
Sofosbuvir/*therapeutic use
Aged ; Antiviral Agents/adverse effects ; Benzimidazoles/therapeutic use ; Comparative Effectiveness Research ; Female ; Fluorenes/therapeutic use ; Genotype ; Hepacivirus/genetics ; Hepatitis C, Chronic/diagnosis ; Hepatitis C, Chronic/virology ; Humans ; Imidazoles/therapeutic use ; Male ; Middle Aged ; Retrospective Studies ; Ribavirin/therapeutic use ; Sofosbuvir/adverse effects ; Sustained Virologic Response ; Taiwan ; Time Factors ; Treatment Outcome ; Uridine Monophosphate/analogs & derivatives ; Uridine Monophosphate/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies